Editas Medicine, Inc. (EDIT) Stock Price History
Historical prices from 2016 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
EDIT Stock Price Trajectory (2016–2026)
As of March 2, 2026, Editas Medicine, Inc. (EDIT) trades at $2.20, representing a +14.6% return over the past year. The stock has delivered a -45.8% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $99.95 on January 8, 2021. From this peak, EDIT has corrected -97.8%, currently trading 13% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ALNY (+34.9% 1Y), IONS (+144.5% 1Y), and ARWR (+234.6% 1Y), EDIT has underperformed the peer group average. Compare EDIT vs ALNY →
Historical Price Data
Showing 30 of 2,533 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 2.11 | 2.29 | 2.11 | 2.20 | 2 | +0.92% |
| 2026-02-26 | 2.13 | 2.22 | 2.06 | 2.18 | 2 | +2.35% |
| 2026-02-25 | 2.15 | 2.23 | 2.09 | 2.13 | 2 | +0.95% |
| 2026-02-24 | 1.91 | 2.29 | 1.91 | 2.11 | 2 | +11.64% |
| 2026-02-23 | 1.76 | 1.91 | 1.76 | 1.89 | 1 | +5.59% |
| 2026-02-20 | 1.77 | 1.80 | 1.73 | 1.79 | 1 | -1.10% |
| 2026-02-19 | 1.71 | 1.81 | 1.67 | 1.81 | 1.48M | +5.23% |
| 2026-02-18 | 1.72 | 1.76 | 1.70 | 1.72 | 975K | -0.29% |
| 2026-02-17 | 1.70 | 1.75 | 1.70 | 1.73 | 130K | -1.99% |
| 2026-02-13 | 1.70 | 1.83 | 1.69 | 1.76 | 1.33M | +4.76% |
| 2026-02-12 | 1.81 | 1.81 | 1.67 | 1.68 | 1.55M | -5.08% |
| 2026-02-11 | 1.79 | 1.81 | 1.70 | 1.77 | 963K | -0.56% |
| 2026-02-10 | 1.82 | 1.84 | 1.77 | 1.78 | 1.23M | -1.66% |
| 2026-02-09 | 1.79 | 1.83 | 1.74 | 1.81 | 1.02M | -0.55% |
| 2026-02-06 | 1.78 | 1.84 | 1.73 | 1.82 | 1.92M | +9.31% |
| 2026-02-05 | 1.92 | 1.95 | 1.66 | 1.67 | 2.21M | -14.62% |
| 2026-02-04 | 2.06 | 2.06 | 1.93 | 1.95 | 1.36M | -5.34% |
| 2026-02-03 | 2.02 | 2.11 | 1.97 | 2.06 | 1.63M | +2.49% |
| 2026-02-02 | 1.99 | 2.07 | 1.95 | 2.01 | 1.54M | +1.01% |
| 2026-01-30 | 2.03 | 2.06 | 1.92 | 1.99 | 1.72M | -3.40% |
| 2026-01-29 | 2.05 | 2.11 | 2.01 | 2.06 | 1.32M | 0.00% |
| 2026-01-28 | 2.13 | 2.13 | 2.02 | 2.06 | 1.37M | -2.37% |
| 2026-01-27 | 2.08 | 2.17 | 2.06 | 2.11 | 1.28M | +2.43% |
| 2026-01-26 | 2.16 | 2.16 | 2.05 | 2.06 | 1.38M | -4.63% |
| 2026-01-24 | 2.38 | 2.39 | 2.15 | 2.16 | 2.23M | 0.00% |
| 2026-01-23 | 2.38 | 2.39 | 2.15 | 2.16 | 2.25M | -9.24% |
| 2026-01-22 | 2.14 | 2.43 | 2.11 | 2.38 | 3.56M | +12.26% |
| 2026-01-21 | 2.02 | 2.12 | 2.02 | 2.12 | 1.99M | +4.95% |
| 2026-01-20 | 1.99 | 2.06 | 1.92 | 2.02 | 1.74M | -0.49% |
| 2026-01-16 | 2.10 | 2.10 | 2.00 | 2.03 | 2.20M | -2.87% |
See EDIT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EDIT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare EDIT vs AGIO
See how EDIT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has EDIT stock performed recently?
EDIT returned +14.6% over the past year, beating its 5-year annualized CAGR of -45.8%. The stock trades below its 200-day moving average, confirming the uptrend.
What is EDIT's all-time high price?
Editas Medicine, Inc. reached $99.95 on 2021-01-08. The 52-week high is $4.54. Current 1-year return of +14.6% places the stock closer to historical peaks.
Where can I download EDIT historical price data?
This page provides EDIT daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.